Mumbai : Indian pharmaceutical major Glenmark Pharmaceuticals Ltd. (Glenmark) has announced that it has been listed in the Dow Jones Sustainability Index (DJSI), under the category of emerging markets for the fourth consecutive year.
DJSI is one of the world’s most respected and widely accepted sustainability benchmarks globally with only the top ranked companies in terms of Corporate Sustainability within each industry featured in the index. The DJSI analyses companies on their corporate economic, environmental and social performance, to assess issues such as but not limited to corporate governance, risk management, environmental policy & management systems, supply chain management, occupational health and safety, labor practices, innovation and cyber security amongst others. Inclusion in this list is considered highly prestigious by global investors, financial analysts and other stakeholders and serves as a benchmark for investors who integrate sustainability considerations into their portfolios.
Over 800 companies across sectors from the emerging markets were assessed, out of which around 108 made it to the prestigious index this year including 15 from India. Glenmark is one of the only five companies from the Pharmaceuticals, Biotechnology & Life Sciences sector to be featured in the DJSI Emerging Markets 2021.